Trial Profile
An Open, Randomized, Two-Treatment, Crossover Study to Assess the Dose Proportionality of Glimepiride Between Amaryl M SR 1/500mg and 2/500mg (Glimepiride-Metformin Fixed Dose Combination Tablet) in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Glimepiride/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Handok Inc
- 27 Oct 2011 Results published in the Clinical Therapeutics.
- 16 Feb 2010 Results will be presented at the 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 15 Jul 2009 New trial record